ehealth radio network
Episodes
![The 9 Carbs to Avoid for a Healthy Life](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/AddictoCarbDiet.png)
Friday Mar 25, 2016
The 9 Carbs to Avoid for a Healthy Life
Friday Mar 25, 2016
Friday Mar 25, 2016
Dr. Bruce Roseman the author of book "The Addictocarb Diet: Avoid the 9 Highly Addictive Carbs while Eating Anything Else You Want" joins eHealth Radio and the Diabetes, and Health News Channels. Dr. Roseman is a family doctor in practice in Manhattan for over 30 years affiliated with Mount Sinai Hospital.
Listen to interview with host Eric Michaels and guest Dr. Bruce Roseman discuss the following:Why are certain carbs so dangerous?
Why did you write “The Addictocarb Diet?”
What are the steps to take to eliminate a carb addiction?It seems simple, but why can’t people shake the addiction?Why does your diet, as opposed to Weight Watchers, work?Does your diet prohibit chocolate?
What foods do you recommend that listeners eliminate as everyone thinks about weight loss and resolutions to live healthier?
Duration: 32:26
Dr. Bruce Roseman has been a Family Doctor in private practice in Manhattan for 30 years, and is affiliated with Mount Sinai Hospital where he holds joint appointments in the departments of Family Medicine and Ob/Gyn.
He has served as medical editor for several food/health-related books and magazines including The Olive Oil Cookbook, The Low Cholesterol Oat Cure, Whittle’s The Health Report, Big Bird Goes to the Doctor (Sesame Street), and as a medical columnist for Woman’s World.
Dr. Roseman has appeared on numerous television and radio programs as a medical expert, including Live Wire (PBS), The Human Condition (NPR) Good Day New York, The Queen Latifah Show, and The Joan Lunden Show, and has been featured in magazines such as Guideposts and Parent.
He is also the author of A Kid Just Like Me (Penguin/Putnam, 2001), which details a popular method he invented to teach children with learning disabilities to read, while working with his son.
Dr. Roseman lives happily, in New York City, with his wife of over a quarter century, Ellen, and is proud to be the father of two fine young men, Joshua and Aaron.
Website: www.addictocarb.com
Facebook: https://www.facebook.com/addictocarb
![Managing Diabetes in the Digital World – Introducing the DARIO](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/DARIO-logo.jpg)
Wednesday Sep 09, 2015
Managing Diabetes in the Digital World – Introducing the DARIO
Wednesday Sep 09, 2015
Wednesday Sep 09, 2015
Todd Durniak, Executive VP of US Operations at Labstyle Innovations that powers the DARIO, a unique diabetes management platform that allows patients and doctors seamlessly manage their condition joins eHealth Radio and the Diabetes, Health News & Technology Channels.Listen to interview with host Eric Michaels and guest Todd Durniak discuss the following: For those living with diabetes, what would you say is the major challenge in managing this condition today?How can your platform technology, Dario™ Diabetes Management Solution address this challenge? Can you explain how it works with smart devices such as phones and ipads? There’s a lot of technology out there to help People with Diabetes manage their disease. How is DARIO different?Aside from the DARIO user, who else can access remotely the blood sugar meter readings? Why is this information important? Labstyle Innovations has an online Facebook community called the DARIO Lounge. Why are these community groups so important in helping patients stay compliant and healthy? The DARIO platform also includes a suite of apps for the smartphone -- How do they work in the overall success for diabetic patients? Would the apps be available for non-diabetic patients?Can you share where the DARIO is currently available and when will be available for US patients?
Duration: 9:26
Todd Durniak is Labstyle Innovations’s Senior Vice President and General Manager for the U.S. Durniak brings to LabStyle over 20 years of medical device commercial and technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering insulin supplies through durable medical equipment (DME) and pharmacy channels with a 'high touch' training approach.
Prior to Insulet and Neighborhood Diabetes, Durniak held a number of positions of increasing responsibility over 7 years at Smith & Nephew Orthopedics, most recently as President, Asia Pacific, based in Sydney, Australia.
Durniak began his career in engineering with Johnson & Johnson Orthopedics, leaving to start and manage Texas Direct Medical, an orthopedic product distributorship. He later re-joined Johnson & Johnson post the acquisition of DePuy, moving through a series of positions before joining Guidant just prior to its acquisition by Boston Scientific.
Durniak holds a BS of Engineering in Biomedical Engineering from the University of Vermont and an MBA from Boston University.
Website: www.MyDario.com
![Oral Insulin and Diabetes: How Close are we to this Medical Breakthrough?](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/OramedPharma.png)
Wednesday Aug 05, 2015
Oral Insulin and Diabetes: How Close are we to this Medical Breakthrough?
Wednesday Aug 05, 2015
Wednesday Aug 05, 2015
Josh Hexter, Chief Operating Officer of Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems including what would be the first oral formulation of insulin joins eHealth Radio and the Diabetes, Pharmaceutical, & Health News Channels.
Listen to interview with host Eric Michaels and guest Josh Hexter discuss the following:Many listeners may be familiar with diabetes, either they are affected or know a family member affected by the condition. Can you explain to our listeners the differences between the Type I and II diabetes? What toll does this disease create?What role does insulin play in diabetes? Why has it taken so long for researchers to turn insulin into a pill? What has been the challenges? Your company is working on an oral version of insulin. Can you describe how does it work and what stage are you in drug’s development? Can you explain why treating patients who may be at risk for Type II diabetes (prediabetes) with Oramed’s oral pill? What protection does the oral version of insulin provide?
Duration: 14:35
Mr. Hexter serves as Chief Operating Officer and Vice President of Business Development of Oramed Pharmaceuticals, which he joined in 2013. He brings to Oramed more than 15 years of prominent leadership, business development, operations know-how and management in the life science sector. He was most recently Executive Director of Corporate In-Licensing at BioLineRx Prior to joining BioLineRx, he worked in private equity and venture capital where he served as CEO of a VC-backed startup.
As CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging business development agreements with Fortune 100 companies in the areas of food safety, medical diagnostics and homeland security. Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.
Website: www.oramed.com
![Glucose Health Assists Type 2 Diabetes Patients in New Product Category](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/GlucoseHealth.png)
Tuesday Jun 30, 2015
Glucose Health Assists Type 2 Diabetes Patients in New Product Category
Tuesday Jun 30, 2015
Tuesday Jun 30, 2015
Kelly Coughlin, the Corporate Spokeswoman and PR Advisor to Glucose Health, Inc. that helps keep your blood sugar balanced joins eHealth Radio and the Diabetes, Health News & Supplement Channels.
Listen to interview with host Eric Michaels & guest Kelly Coughlin discuss the following:What is Glucose Health and why is it an important component of combating Type 2 diabetes?What are the active ingredients in the product?Who developed the formula for Glucose Health?Why is this product different from others on the market?Type 2 diabetes is becoming an epidemic in the U.S.; can Glucose Health help lower the number of affected Americans?Share with us if you would success stories of people using this product.When will Glucose Health be available to consumers in mass market?Where can consumers purchase the product now?
Duration: 9:55
The Centers for Disease Control and Prevention estimates two in five Americans will develop Type 2 diabetes in their lifetime. Addressing the key lifestyle factors that lead to Type 2 diabetes today, will keep you healthy in the future! Make Glucose Health® a part of your commitment to healthy living. Certain clinical studies indicate the 6 key natural ingredients in the Glucose Health® formula have important relationships to glucose, insulin, triglycerides and HDL ("good" cholesterol).
Kelly Coughlin is President of Annex Communication. For a decade and a half, Kelly Coughlin has worked as a publicist and strategist between the CPG/retail, healthcare, real estate, media, and sports & entertainment industries.
Her experience includes: building national advertising and public relations platforms, negotiation and creation of national media and sports/entertainment sponsorships, creation of Interactive platforms supported by SEO/SEM practices, and high-profile individual management. Ms. Coughlin has represented entertainers, athletes, physicians, Fortune 500 executives, national brands, sports organizations, festivals and tours, real estate companies and retailers.
Ms. Coughlin holds a B.A. in Communication from Boston College.
Website: www.glucosehealth.com
![New Advances in Diabetes Treatment: Insulin-Producing Cells That Could Replace Injections](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/PharmaCyteBiotech-logo.png)
Wednesday May 20, 2015
Wednesday May 20, 2015
Dr. Gerald Crabtree, Chief Operating Officer and Director at PharmaCyte Biotechnology, a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box joins eHealth Radio and the Diabetes and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Gerald Crabtree discuss the following:In an effort to understand how the Melligen cells works, can you explain what happens to the pancreas in Type 1 diabetes?Why are liver cells such good candidates to replace the damaged cells in the pancreas?What have early lab trials shown?How does PharmaCyte’s Cell-in-the-Box help the melligen cells do their jobs?How will this technology help the lives of those patients living with Type 1 Diabetes?
Duration: 15:55
Dr. Gerald Crabtree is PharmaCyte’s Chief Operating Officer. Since 1985, Dr. Crabtree has been involved with various biopharmaceutical companies where he has alternatively supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, and research and review articles and served as project manager for development of major oncologic agents. He is a Member of the American Society of Clinical Oncology and also is a past member of research grant review committees for the National Institute of Health and the American Cancer Society. Dr. Crabtree established and directed, from inception, a department that monitored and coordinated the development of oncologic and immunologic drugs from initial discovery through regulatory approval in a major pharmaceutical company and served as project manager for the development of the anticancer agent, Taxol®.
Dr. Crabtree received his Ph.D. in Biochemistry from the University of Alberta, Edmonton, Alberta, Canada and has published over 80 articles in peer-reviewed journals. He is a National Cancer Institute of Canada Research Fellow. In addition, he served as Department Head of Molecular Pharmacology for the Nucleic Acid Research Institute, and prior to that as Associate Professor of Medicine with the Roger Williams Cancer Center at Brown University. Dr. Crabtree has also served as Director of Project Planning and Management (Oncology/Immunology) at Bristol-Myers Squibb and as Vice-President of Research and Development at ETEX Corporation.
Website: www.pharmacytebiotech.com
![Eat Chew Live, offering a revolutionary way of preventing, and even reversing diabetes](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/EatChewLive_SMALL.jpg)
Saturday Apr 04, 2015
Saturday Apr 04, 2015
Dr. John Poothullil, Author of Eat Chew Live, a new book that offers a revolutionary way of preventing, and even reversing diabetes joins eHealth Radio and the Diabetes and Health News Channels.
Listen to interview with host Eric Michaels & guest Dr. John Poothullil discuss the following:What is different or new in your book that others have not already said about diabetes?What is your theory about the cause of diabetes? It is believed that diabetes can be controlled, but you suggest that it can be reversed, tell us how? Your book says, “How you eat is more important than what you eat.” What does this mean?Experts say that eating whole grain foods is beneficial because they contain vitamins. Your book doesn't seem to support that claim. Why?
Tip: The one thing you can do on a daily basis to prevent diabetes is to listen to your body and to be fully present while you are eating, so your body can tell you what it needs to prevent overeating, habitual eating, stress eating, and other behaviors that don't serve our health.
John Poothullill, MD, FRCP practiced medicine as a pediatrician and allergist for more than 30 years. He holds certifications from the American Board of Pediatrics, The American Board of Allergy & Immunology, and the Canadian Board of Pediatrics.
Dr. Poothullil has written articles on hunger and satiation, weight loss, diabetes, and the senses of taste and smell. He has been published in medical journals such as Physiology and Behavior, Neuroscience and Biobehavioral Reviews, Journal of Women’s Health, Journal of Applied Research, Nutrition, and Nutritional Neuroscience. His work has been quoted in Woman’s Day, Fitness, Red Book and Woman’s World.
Dr. Poothullil resides in Portland, OR.
Website: www.eatchewlive.com
![Journey to a Miracle: Freedom from Insulin](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/SMALL_10620502_318574415020344_8789636694638105331_o.jpg)
Wednesday Feb 25, 2015
Journey to a Miracle: Freedom from Insulin
Wednesday Feb 25, 2015
Wednesday Feb 25, 2015
Laurie Jaffe with her husband Mike are the driving force behind a new documentary Journey to a Miracle: Freedom of Insulin joins eHealth Radio and the Diabetes and Health News Channels.
Listen to interview with host Eric Michaels and guest Laurie Jaffe discuss the following: What is monogenic diabetes? How does it differ from type 1?How is it tested and should anyone with diabetes be tested? What is the process?Why do you think there is such a large amount of people that are unaware?What are the obstacles those with type 1 might face? And what are the Solutions?What is your message in producing and releasing the documentary Journey to a Miracle: Freedom of Insulin
Duration: 16:15
Laurie Jaffe and her husband Mike are the driving force behind a new documentary Journey to a Miracle: Freedom of Insulin. They were inspired to produce the film after their daughter Lilly, who was diagnosed with diabetes at one month old, was able to disconnect her insulin pump for good at age 6 after doctors discovered that she did not actually have type-1 diabetes.
In 2006, Mike attended a JDRF meeting where Dr. Louis Philipson of the University of Chicago Kovler Diabetes Center spoke of an upcoming study in the New England Journal of Medicine involving children diagnosed with diabetes as babies. Dr. Philipson explained that most of the children did not actually have type 1 diabetes, but rather a newly understood genetic form called monogenic that is best treated with oral medication, not insulin shots. The rest is history. The Jaffes made a forever friend in Dr. Philipson who became Lilly’s doctor and helped her transition from insulin to oral medication at the University of Chicago.
Moved by their family’s miracle and the potential of reaching thousands more, the Jaffes felt passionate about helping to raise global awareness of monogenic diabetes. They initiated monogenicdiabetes.org, an authoritative website now administered by the Kovler Diabetes Center. Laurie also began and moderated an on-line discussion/support group for parents whose children were also able to switch their treatment from insulin shots to oral medication. The close-knit group grew as parents contacted Laurie after hearing about their family’s story. The group eventually met in person in 2010 and 2013 at “Celebrating the Miracles” conferences hosted by the Kovler Diabetes Center to bring scientists and families together. Laurie is a founding Leadership Board member of the University of Chicago Kovler Diabetes Center.
Website: www.journeytoamiraclemovie.comFacebook: facebook.com/journeytoamiracle
![How diabetic families of can encourage healthy weight loss](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/CFH_Logo250x250.jpg)
Sunday Oct 26, 2014
How diabetic families of can encourage healthy weight loss
Sunday Oct 26, 2014
Sunday Oct 26, 2014
Dr. Lorraine Platka-Bird, Dietician at Center for Hope of the Sierras, a specialized eating disorder treatment facility in Reno, Nevada joins eHealth Radio and the Diabetes and Eating Disorder Channels.
Listen to interview with host Eric Michaels & guest Dr. Lorraine Platka-Bird discuss the following: I’ve heard about anorexia and bulimia, but what is Diabulimia?What are the symptoms of Diabulimia?How can diabetics find a healthy weight without dangerously altering their insulin levels?How can diabetics learn what insulin level is best for them?Eating disorders are often thought of as being entirely controlled and self-inflicted, are people sick with an eating disorder really in control? Since there is such an overlap between the physical and psychological aspects, what kind of facility should someone with Diabulimia be treated at?
Duration: 9:51
Dr. Lorraine Platka-Bird has been counseling individuals with eating disorders for more than 25 years. She takes a holistic approach to treatment, considering all aspects of physical, mental, social, emotional, and spiritual well-being. In addition to helping clients develop a healthy relationship with food, Dr. Platka-Bird helps individuals minimize eating disorder thoughts and behaviors, improve self-image and self-esteem, and develop healthy coping skills and life skills to improve overall quality of life.
Links:
Website: www.centerforhopeofthesierras.crchealth.com
Facebook: www.facebook.com/centerforhopeofthesierrasfan
Twitter: @Centerforhope
![If I Kiss You, Will I Get Diabetes with diabetes advocate Quinn Nystrom](https://deow9bq0xqvbj.cloudfront.net/image-logo/440892/eHealthRadio_LOGO2020_300x300.jpg)
Wednesday May 07, 2014
If I Kiss You, Will I Get Diabetes with diabetes advocate Quinn Nystrom
Wednesday May 07, 2014
Wednesday May 07, 2014
Quinn Nystrom, diabetes advocate and author of “If I Kiss You, Will I Get Diabetes” joins eHealth Radio and the Diabetes and Health News Channels. Her company, Qspeak, allows her to advocate, consult and raise funds for diabetes research.
Listen to interview with host Eric Michaels & guest Quinn Nystrom discuss the following:What are the biggest misconceptions about diabetes?What have you learned from living with diabetes?What motivated you to write this book, "If I Kiss You, Will I Get Diabetes?"You've been publicly vocal about Joan River's recent comments about diabetes. As she stated, "Get fat. Get diabetes. Die. Lose your fingers." What upset you the most about this? What do you hope people will walk away with after hearing you speak or reading your book?
Duration: 14:19
Quinn Nystrom is one of those unique individuals that commands a presence. Whether she’s speaking to an audience of teenagers or adults, Nystrom can relate to both and with the launch of her new book, IF I KISS YOU, WILL I GET DIABETES? for River Place Press, you’ll be hearing her name a lot.
Inspired by her teenage self, the book is Nystrom’s first-hand account of negotiating life with a chronic illness and she now devotes her full-time efforts to diabetes advocacy and has been recognized nationally for her contributions.
For the past 17 years, she has been sharing her story of living with type-1 diabetes to audiences across the country. As the National Youth Advocate for the American Diabetes Association (ADA) she spent a year traveling to diabetes camps, convention halls, the White House, corporate offices and the United States Congress. Her message was simple: Find a cure for diabetes and provide support and care for the millions of people living with the disease.
Nystrom grew up in Brainerd, Minnesota with her younger brother Will who was diagnosed with Type 1 diabetes when he was five years old. By age ten, she was fundraising and going door to door in her small town to raise money for a cure for her baby brother’s disease. However, three years later, Nystrom was diagnosed with Type 1 and her goal to finding a cure became a lifelong mission. She was named the National Youth Advocate for the American Diabetes Association (ADA) at age sixteen and spent a year traveling across the country. Her message was simple; find a cure for diabetes and support the millions of Americans living with it.
Currently a graduate student at Syracuse University in Communication's Management, Nystrom attends S.I. Newhouse School of Public Communications, ranked #1 in the country with alums such as Bob Costas and Dick Clark. As a public speaker she travels across the country to diabetes camps, convention halls, corporate offices, United States Congress and yes, The White House. Her company, Qspeak, allows her to advocate, consult and raise funds for diabetes. A portion of the books proceeds goes to the non-profit she founded called Dateline Diabetes, whose mission is to provide support for people living with diabetes.
Nystrom currently lives in Minneapolis where she enjoys skating on the lakes, making her monthly dinner club with childhood friends, and volunteering at her local church.
Web Site: quinnnystrom.comFacebook: facebook.com/QuinnNystromTwitter: @quinnnystrom
![ActiveCare, a real-time patient monitoring company](https://deow9bq0xqvbj.cloudfront.net/ep-logo/pbblog440892/ActiveCarelogo.jpg)
Friday Aug 09, 2013
ActiveCare, a real-time patient monitoring company
Friday Aug 09, 2013
Friday Aug 09, 2013
Michael Jones, an executive with ActiveCare a Utah based, real-time patient monitoring company joins eHealth Radio and the Health Care and Technology Channels. Jones is an expert in the medical monitoring field, especially as it relates to monitoring the Type 2 diabetic population here in America.
Listen to interview with host Eric Michaels & guest Michael Jones discuss the following:What is the primary focus of your company, ActiveCare?Please speak on how ActiveCare improves the quality of life of its members.When we think diabetes, especially Type 2 diabetes, many look down on the sufferers saying, “It’s an eating issue, or a self-inflicted health issue.” What can a person do to overcome this stigma?Have you seen an increase in diabetics drawn to your service to improve their quality of life?What advice can you offer a Type 2 diabetes patient who’s looking for a positive change in handling their disease?Duration: 13:35
Michael has been a founder and executive in several of the technology industry’s fastest growing companies. Mr. Jones founded Interactive Care in 2007, filing several patents in the field of video collaboration as a tool for delivery of medical care. As Executive Vice President at RemedyMD, Michael led in the advancement of medical collaboration and the utilization of informatics technologies for the treatment of obesity and diabetes.
While Executive Vice President of Sales and Marketing at iBahn (formerly STSN), the company was recognized in consecutive years by Deloitte & Touche and Inc. Magazine for its explosive growth, expanding from $29M to over $120M in annual sales over a three-year period.
Prior to iBahn, Mr. Jones led numerous sales and operations organizations at Iomega Corporation during a period of unprecedented growth, exponentially expanding its distribution, customer support, production and logistics capacities. Michael has also led in domestic and international senior sales leadership roles at Siebel Systems, Silicon Graphics and Oracle. A published author and contributor to periodicals and industry publications, Michael graduated from the University of Utah with a degree in English.
Links: www.activecare.com